{"entity":{"type":"insider","cik":"0001632237","url":"/insider/0001632237","json_url":"/insider/0001632237.json","name":"Benaim Ely","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":17,"first":"2020-05-12","last":"2022-08-04","span_basis":"filed_date"},"name_variants":[{"name":"Benaim Ely","source":"filing","n_filings":17,"first_seen":"2020-05-12","last_seen":"2022-08-04"}],"transactions":[{"id":6733306,"accession":"0001645113-22-000073","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-22-000073","line_url":"/filing/0001645113-22-000073","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5959.0,"shares_display":"5,959","price_per_share":73.72506628628965,"price_display":"73.73","price_state":"stated","total_value":439327.67,"total_display":"439,327.67","total_whole":"439,328","shares_owned_after":28672.0,"shares_owned_after_display":"28,672","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-03","filed_date":"2022-08-04","scope":"insider","n_lines":2},{"id":6981256,"accession":"0001645113-22-000070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-22-000070","line_url":"/filing/0001645113-22-000070#line-1","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":437.0,"shares_display":"437","price_per_share":69.659,"price_display":"69.66","price_state":"stated","total_value":30440.983,"total_display":"30,440.98","total_whole":"30,441","shares_owned_after":34631.0,"shares_owned_after_display":"34,631","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-02","filed_date":"2022-08-03","scope":"insider"},{"id":6733301,"accession":"0001645113-22-000046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-22-000046","line_url":"/filing/0001645113-22-000046#line-2","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2135.0,"shares_display":"2,135","price_per_share":61.25,"price_display":"61.25","price_state":"stated","total_value":130768.75,"total_display":"130,768.75","total_whole":"130,769","shares_owned_after":34846.0,"shares_owned_after_display":"34,846","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-11","filed_date":"2022-05-12","scope":"insider"},{"id":6733300,"accession":"0001645113-22-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-22-000046","line_url":"/filing/0001645113-22-000046#line-1","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2070.0,"shares_display":"2,070","price_per_share":65.158,"price_display":"65.16","price_state":"stated","total_value":134877.06,"total_display":"134,877.06","total_whole":"134,877","shares_owned_after":36981.0,"shares_owned_after_display":"36,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-10","filed_date":"2022-05-12","scope":"insider"},{"id":6334580,"accession":"0001645113-22-000017","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001645113-22-000017","line_url":"/filing/0001645113-22-000017#line-3","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1510.0,"shares_display":"1,510","price_per_share":70.407,"price_display":"70.41","price_state":"stated","total_value":106314.57,"total_display":"106,314.57","total_whole":"106,315","shares_owned_after":43257.0,"shares_owned_after_display":"43,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-04","filed_date":"2022-03-07","scope":"insider"},{"id":6334573,"accession":"0001645113-22-000017","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-22-000017","line_url":"/filing/0001645113-22-000017#line-2","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":803.0,"shares_display":"803","price_per_share":74.498,"price_display":"74.50","price_state":"stated","total_value":59821.894,"total_display":"59,821.89","total_whole":"59,822","shares_owned_after":44767.0,"shares_owned_after_display":"44,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-03","filed_date":"2022-03-07","scope":"insider"},{"id":4334664,"accession":"0001645113-21-000095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-21-000095","line_url":"/filing/0001645113-21-000095#line-1","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":464.0,"shares_display":"464","price_per_share":150.11,"price_display":"150.11","price_state":"stated","total_value":69651.04,"total_display":"69,651.04","total_whole":"69,651","shares_owned_after":28144.0,"shares_owned_after_display":"28,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-04","scope":"insider"},{"id":5339899,"accession":"0001645113-21-000094","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001645113-21-000094","line_url":"/filing/0001645113-21-000094#line-3","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":536.0,"shares_display":"536","price_per_share":149.378,"price_display":"149.38","price_state":"stated","total_value":80066.608,"total_display":"80,066.61","total_whole":"80,067","shares_owned_after":28608.0,"shares_owned_after_display":"28,608","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-03","scope":"insider"},{"id":5339895,"accession":"0001645113-21-000094","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-21-000094","line_url":"/filing/0001645113-21-000094#line-2","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":651.0,"shares_display":"651","price_per_share":158.96,"price_display":"158.96","price_state":"stated","total_value":103482.96,"total_display":"103,482.96","total_whole":"103,483","shares_owned_after":29144.0,"shares_owned_after_display":"29,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-30","filed_date":"2021-08-03","scope":"insider"},{"id":4152578,"accession":"0001645113-21-000069","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-21-000069","line_url":"/filing/0001645113-21-000069#line-2","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1833.0,"shares_display":"1,833","price_per_share":200.0,"price_display":"200.00","price_state":"stated","total_value":366600.0,"total_display":"366,600.00","total_whole":"366,600","shares_owned_after":29054.0,"shares_owned_after_display":"29,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-27","filed_date":"2021-05-28","scope":"insider"},{"id":5230553,"accession":"0001645113-21-000068","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-21-000068","line_url":"/filing/0001645113-21-000068#line-1","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1943.0,"shares_display":"1,943","price_per_share":180.48,"price_display":"180.48","price_state":"stated","total_value":350672.64,"total_display":"350,672.64","total_whole":"350,673","shares_owned_after":29054.0,"shares_owned_after_display":"29,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-14","scope":"insider"},{"id":5123710,"accession":"0001645113-21-000067","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001645113-21-000067","line_url":"/filing/0001645113-21-000067#line-3","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2262.0,"shares_display":"2,262","price_per_share":180.118,"price_display":"180.12","price_state":"stated","total_value":407426.916,"total_display":"407,426.92","total_whole":"407,427","shares_owned_after":30997.0,"shares_owned_after_display":"30,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-12","scope":"insider"},{"id":5123709,"accession":"0001645113-21-000067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-21-000067","line_url":"/filing/0001645113-21-000067#line-2","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1833.0,"shares_display":"1,833","price_per_share":189.65,"price_display":"189.65","price_state":"stated","total_value":347628.45,"total_display":"347,628.45","total_whole":"347,628","shares_owned_after":33259.0,"shares_owned_after_display":"33,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-10","filed_date":"2021-05-12","scope":"insider"},{"id":4910450,"accession":"0001645113-21-000053","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001645113-21-000053","line_url":"/filing/0001645113-21-000053","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5958.0,"shares_display":"5,958","price_per_share":200.0,"price_display":"200.00","price_state":"stated","total_value":1191600.0,"total_display":"1,191,600.00","total_whole":"1,191,600","shares_owned_after":33259.0,"shares_owned_after_display":"33,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-13","filed_date":"2021-04-15","scope":"insider","n_lines":3},{"id":5339873,"accession":"0001645113-21-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-21-000041","line_url":"/filing/0001645113-21-000041#line-1","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2918.0,"shares_display":"2,918","price_per_share":131.53,"price_display":"131.53","price_state":"stated","total_value":383804.54,"total_display":"383,804.54","total_whole":"383,805","shares_owned_after":33259.0,"shares_owned_after_display":"33,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-09","scope":"insider"},{"id":5473649,"accession":"0001645113-21-000036","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001645113-21-000036","line_url":"/filing/0001645113-21-000036#line-3","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Restricted Share Units","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1888.0,"shares_display":"1,888","price_per_share":137.554,"price_display":"137.55","price_state":"stated","total_value":259701.952,"total_display":"259,701.95","total_whole":"259,702","shares_owned_after":36177.0,"shares_owned_after_display":"36,177","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-04","filed_date":"2021-03-05","scope":"insider"},{"id":5473645,"accession":"0001645113-21-000036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-21-000036","line_url":"/filing/0001645113-21-000036#line-2","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3475.0,"shares_display":"3,475","price_per_share":150.78,"price_display":"150.78","price_state":"stated","total_value":523960.5,"total_display":"523,960.50","total_whole":"523,961","shares_owned_after":38065.0,"shares_owned_after_display":"38,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-03","filed_date":"2021-03-05","scope":"insider"},{"id":2158435,"accession":"0001628280-20-017712","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-20-017712","line_url":"/filing/0001628280-20-017712","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2484.0,"shares_display":"2,484","price_per_share":156.71,"price_display":"156.71","price_state":"stated","total_value":389267.64,"total_display":"389,267.64","total_whole":"389,268","shares_owned_after":29356.0,"shares_owned_after_display":"29,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-21","filed_date":"2020-12-22","scope":"insider","n_lines":2},{"id":2548720,"accession":"0001645113-20-000115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-20-000115","line_url":"/filing/0001645113-20-000115#line-1","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":660.0,"shares_display":"660","price_per_share":76.06,"price_display":"76.06","price_state":"stated","total_value":50199.6,"total_display":"50,199.60","total_whole":"50,200","shares_owned_after":29356.0,"shares_owned_after_display":"29,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-05","scope":"insider"},{"id":2117738,"accession":"0001645113-20-000114","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-20-000114","line_url":"/filing/0001645113-20-000114#line-2","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":341.0,"shares_display":"341","price_per_share":76.388,"price_display":"76.39","price_state":"stated","total_value":26048.308,"total_display":"26,048.31","total_whole":"26,048","shares_owned_after":30016.0,"shares_owned_after_display":"30,016","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-31","filed_date":"2020-08-03","scope":"insider"},{"id":2158718,"accession":"0001645113-20-000083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-20-000083","line_url":"/filing/0001645113-20-000083#line-1","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2595.0,"shares_display":"2,595","price_per_share":64.78,"price_display":"64.78","price_state":"stated","total_value":168104.1,"total_display":"168,104.10","total_whole":"168,104","shares_owned_after":12616.0,"shares_owned_after_display":"12,616","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-12","filed_date":"2020-05-14","scope":"insider"},{"id":2189019,"accession":"0001645113-20-000079","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-20-000079","line_url":"/filing/0001645113-20-000079#line-2","is_derivative":false,"issuer_cik":"0001632237","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001632237","owner_cik":"0001632237","owner_name":"Benaim Ely","owner_display_name":"Benaim Ely","owner_url":"/insider/0001632237","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1611.0,"shares_display":"1,611","price_per_share":63.728,"price_display":"63.73","price_state":"stated","total_value":102665.808,"total_display":"102,665.81","total_whole":"102,666","shares_owned_after":15211.0,"shares_owned_after_display":"15,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-11","filed_date":"2020-05-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":26,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001645113","name":"NovoCure Ltd","url":"/issuer/0001645113","role":"Officer (Chief Medical Officer)","n_filings":17,"first_seen":"2020-05-12","last_seen":"2022-08-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001632237","retrieved_at":"2026-08-25T04:08:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}